Has Michael Ragosta, MD received payments from drug or device companies?

Yes. Drug and device makers reported $16,532 in general payments to Michael Ragosta, MD across 63 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Ragosta, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Ragosta, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Ragosta, MD

Interventional Cardiology · Charlottesville, VANPI 1376609610

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (55.7%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Medtronic at 47.8% of the total. Reporting peaked in 2023 at $6,395 and has fallen 66.2% since, to $2,160 in 2025.

$16,532in general payments, 2019–2025

Across 63 payments — averaging $262.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$8K
Siemens Medical Solutions USA, Inc.$3K
Boston Scientific$2K
Abbott$2K
Ancora Heart, Inc.$1K
Shockwave Medical, Inc$286
plus $554 from 4 others

$1,012,591in research payments, 2019–2025

Across 311 payments — averaging $3255.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$726K
Medtronic$174K
Biotronik Inc.$70K
Livanova USA, Inc.$26K
Corindus Inc.$6K
Bayer$4K
plus $6K from 2 others

What the payments were for

Consulting fees$1,80011%
Speaking & faculty fees$2,50015%
Travel & lodging$9,20556%
Food & beverage$3,02718%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	28	$7,895
Siemens Medical Solutions USA, Inc.	2	$2,516
Boston Scientific	18	$2,146
Abbott	6	$1,913
Ancora Heart, Inc.	2	$1,222
Shockwave Medical, Inc	1	$286
Verge Medical, Inc.	1	$215
Edwards Lifesciences	2	$171
Novo Nordisk	1	$116
GE HealthCare	2	$51

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

COREVALVE EVOLUT R$7,084
AMPLATZER AMULET$1,800
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$286
AVVIGO Guidance System$258
OSTIAL Flash System$215
GENERAL - STENTS$141

How this compares

$16,532 in reported general payments places this provider in the 80th percentile of 176 interventional cardiology providers in Virginia.

See all interventional cardiology providers in Virginia →

Medicare billing

Part B allowed, 2024

$283,443

Medicare patients

621

Services billed

1,686

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	73	$61,345
Repatha SureclickEvolocumab	21	$25,613
Praluent PenAlirocumab	26	$17,355
Ranolazine ErRanolazine	32	$3,068
SymbicortBudesonide/Formoterol Fumarate	13	$2,930
Ezetimibe	53	$2,167
Isosorbide Mononitrate ErIsosorbide Mononitrate	143	$2,084
Metoprolol Succinate	145	$1,565
Atorvastatin Calcium	151	$1,303
Prasugrel Hcl	18	$1,170
ClopidogrelClopidogrel Bisulfate	163	$964
Rosuvastatin Calcium	73	$759
Lisinopril	63	$580
Nitroglycerin	49	$499
Amlodipine Besylate	60	$493

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Charlottesville

Angela TaylorCharlottesville$119K
John SaxonCharlottesville$116K
Saad GhummanCharlottesville$17K
Kanwar SinghCharlottesville$15K
Deepak TalrejaVirginia Beach$1.5M
Rajiv TayalFredericksburg$984K
Gansevoort DunningtonRichmond$440K
Matthew SummersNorfolk$308K
Noah JonesFalls Church$238K
Michael GenVirginia Beach$207K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →